Detectable systemic exposure was reported following injected administration, while oral administration did not produce detectable peptide levels
Follow these five steps to get an accurate doubling time result
It is an occasion when people come together to light diyas, burst firecrackers, and exchange gifts
Please consult your doctor before using Gthance Tablet
Novo Nordisk files for FDA approval for CagriSema, the first once-weekly combination of GLP1 and amylin analogues owenhaskins Dec 19, 2025 2 min read Novo Nordisk has submitted a New Drug Application (NDA) to the FDA for once-weekly CagriSema (cagrilintide 2.4 mg and semaglutide 2.4 mg) injection, to be used with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults with obesity or overweight in the presence of at least one weight-related comorbid condition
You probably know them best from those fruity, colored sports drinks